DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactSector

Nifty Pharma Prediction for Tomorrow: 23 September 2026 Outlook

Univest 13 hrs ago·22 Sept 2026, 2:53 pm

Investors are closely watching the broader pharma sector for the trading session on 23 September 2026. The market sentiment will likely be driven by the performance of major pharmaceutical companies and the overall health of the industry.

This sector is a key component of the Indian stock market, often providing stability during volatile times. Its performance is influenced by factors such as global demand for generic drugs, regulatory approvals, and domestic healthcare policies.

Moving forward, investors should monitor the movement of leading stocks and any broader market cues. Keeping an eye on sector-specific trends will be crucial for understanding the market's direction in the coming days.